First- and Second-Generation Antipsychotics for Children and Young Adults
Introduction to Antipsychotics in Pediatric Use (3 of 4)
Many first-generation and second-generation antipsychotics are approved by the U.S. Food and Drug Administration (FDA) for use in children and/or adolescents. Recommendations or advertisements that promote the use of pharmaceuticals for indications that have not been approved by the FDA (off-label) are illegal. However, off-label prescribing by physicians is permitted.
- Seida J, Schouten J, Mousavi S, et al. First- and Second-Generation Antipsychotics for Children and Young Adults. Comparative Effectiveness Review No. 39 (Prepared by the University of Alberta Evidence-based Practice Center under Contract No. 290-2007-10021). Rockville, MD: Agency for Healthcare Research and Quality; February 2012. AHRQ Publication No. 11(12)-EHC077-EF. Available at www.effectivehealthcare.ahrq.gov/pedantipsych.cfm.
Your slide tray is being processed.